Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?

作者: Peter E Huber , Juergen Debus , Detlev Latz , Dietmar Zierhut , Marc Bischof

DOI: 10.1016/S0167-8140(00)00273-5

关键词: Radiation therapyHead and neckNuclear medicineNeutronMixed beamHigh-LET RadiotherapyPostoperative radiotherapyAdenoid cystic carcinomaLymphMedicine

摘要: Abstract Purpose : To compare retrospectively radiotherapy with neutrons, photons, and a photon/neutron mixed beam in patients advanced adenoid cystic carcinoma of the head neck. Local control, survival, distant failure, complications were analyzed. Materials methods Between 1983 1995, 75 inoperable, recurrent, or incompletely resected neck received that consisted either fast 14.1 MV DT neutrons (median dose 16 neutron Gy), linac-based photon irradiation 64 both 8 Gy 32 Gy). Follow-up ranged from 1 to 160 months 51 months), surviving had minimum follow-up 3 years at time analysis. Results The actuarial 5-year local control was 75% for 32% photons ( P =0.015, log-rank). This advantage not transferred significant differences survival >0.1). is dictated by tumor diseases due metastases occurring 29 (39%) patients. Positive lymph nodes only factor =0.001) associated development although negative did predict absence metastases, but predicted delay occurrence. In multivariate analysis postoperative =0.003) small size =0.01) high while primary therapy =0.006) longer survival. While acute toxicity similar all three groups, severe late grade 4 tended be more prevalent >0.1) (19%) than (10%) (4%). Conclusion Fast provides higher rates advanced, recurrent completely major minor salivary glands. Neutron can recommended bad prognosis gross residual disease (R2), unresectable tumors, inoperable tumors. type radiation does impact which dominated number metastases.

参考文章(33)
J. M. Debois, Cancer of the Salivary Glands Springer Netherlands. pp. 345- 391 ,(2000) , 10.1007/978-94-011-4100-0_11
M S Kies, D J Haraf, I Athanasiadis, M Kozloff, B Mittal, H Pelzer, A W Rademaker, B Wenig, R R Weichselbaum, E E Vokes, Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. Journal of Clinical Oncology. ,vol. 16, pp. 2715- 2721 ,(1998) , 10.1200/JCO.1998.16.8.2715
Jan.J. Battermann, Klaas Breur, Guus A.M. Hart, Henny A. van Peperzeel, Observations on pulmonary metastases in patients after single doses and multiple fractions of fast neutrons and cobalt-60 gamma rays European Journal of Cancer (1965). ,vol. 17, pp. 539- 548 ,(1981) , 10.1016/0014-2964(81)90056-6
James G. Douglas, George E. Laramore, Mary Austin-Seymour, Wui-Jin Koh, Karen L. Lindsley, Paul Cho, Thomas W. Griffin, Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands International Journal of Radiation Oncology Biology Physics. ,vol. 36, pp. 87- 93 ,(1995) , 10.1016/S0360-3016(96)00213-1
Mary Catterall, R.D. Errington, The implications of improved treatment of malignant salivary gland tumors by fast neutron radiotherapy International Journal of Radiation Oncology Biology Physics. ,vol. 13, pp. 1313- 1318 ,(1987) , 10.1016/0360-3016(87)90222-7
James Y. Suen, Eugene N. Myers, Cancer of the Head and Neck ,(1989)
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Karl Albrecht Schmidt, Günter Reinhold, The haefely-gfk fast-neutron generator International Journal of Radiation Oncology*Biology*Physics. ,vol. 3, pp. 373- 376 ,(1977) , 10.1016/0360-3016(77)90280-2
Karen K. Fu, Steven A. Leibel, Michael L. Levine, Lawrence M. Friedlander, Roger Boles, Theodore L. Phillips, Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer. ,vol. 40, pp. 2882- 2890 ,(1977) , 10.1002/1097-0142(197712)40:6<2882::AID-CNCR2820400618>3.0.CO;2-I
Thomas A. Buchholz, George E. Laramore, Brian R. Griffin, Wui-Jin Koh, Thomas W. Griffin, The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms. Cancer. ,vol. 69, pp. 2779- 2788 ,(1992) , 10.1002/1097-0142(19920601)69:11<2779::AID-CNCR2820691125>3.0.CO;2-N